• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

齐墩果酸通过靶向肠-肝轴缓解代谢紊乱和肝脂肪变性。

Oleanolic Acid Targets the Gut-Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis.

机构信息

Laboratory of Molecular Nutrition and Immunity, Institute of Animal Nutrition, Northeast Agricultural University, Harbin, Heilongjiang 150030, People's Republic of China.

College of Animal Science and Veterinary Medicine, Jinzhou Medical University, Jinzhou, Liaoning 121001, People's Republic of China.

出版信息

J Agric Food Chem. 2021 Jul 21;69(28):7884-7897. doi: 10.1021/acs.jafc.1c02257. Epub 2021 Jul 12.

DOI:10.1021/acs.jafc.1c02257
PMID:34251802
Abstract

This study investigated the effects of oleanolic acid (OA) on hepatic lipid metabolism and gut-liver axis homeostasis in an obesity-related non-alcoholic fatty liver disease (NAFLD) nutritional animal model and explored possible molecular mechanisms behind its effects. The results revealed that OA ameliorated the development of metabolic disorders, insulin resistance, and hepatic steatosis in obese rats. Meanwhile, OA restored high-fat-diet (HFD)-induced intestinal barrier dysfunction and endotoxin-mediated induction of toll-like-receptor-4-related pathways, subsequently inhibiting endotoxemia and systemic inflammation and balancing the homeostasis of the gut-liver axis. OA also reshaped the composition of the gut microbiota of HFD-fed rats by reducing the Firmicutes/Bacteroidetes ratio and increasing the abundance of butyrate-producing bacteria. Our results support the applicability of OA as a treatment for obesity-related NAFLD through its anti-inflammatory, antioxidant, and prebiotic integration responses mediated by the gut-liver axis.

摘要

本研究旨在探讨齐墩果酸(OA)对肥胖相关非酒精性脂肪性肝病(NAFLD)营养性动物模型肝内脂质代谢和肠-肝轴稳态的影响,并探讨其作用的可能分子机制。结果表明,OA 可改善肥胖大鼠的代谢紊乱、胰岛素抵抗和肝脂肪变性。同时,OA 恢复了高脂肪饮食(HFD)诱导的肠道屏障功能障碍和内毒素介导的 toll 样受体 4 相关途径的诱导,从而抑制内毒素血症和全身炎症,平衡肠-肝轴的稳态。OA 还通过减少厚壁菌门/拟杆菌门的比例和增加丁酸产生菌的丰度,重塑 HFD 喂养大鼠的肠道微生物群落组成。我们的研究结果支持 OA 通过肠-肝轴介导的抗炎、抗氧化和益生元整合反应,作为治疗肥胖相关 NAFLD 的一种应用。

相似文献

1
Oleanolic Acid Targets the Gut-Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis.齐墩果酸通过靶向肠-肝轴缓解代谢紊乱和肝脂肪变性。
J Agric Food Chem. 2021 Jul 21;69(28):7884-7897. doi: 10.1021/acs.jafc.1c02257. Epub 2021 Jul 12.
2
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.槲皮素对高脂饮食诱导的小鼠非酒精性脂肪性肝病的保护作用是通过调节肠道微生物群失衡和相关肠-肝轴激活来介导的。
Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.
3
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.用白藜芦醇靶向肠道微生物群:管理肝脂肪变性的新证据的例证。
J Nutr Biochem. 2020 Jul;81:108363. doi: 10.1016/j.jnutbio.2020.108363. Epub 2020 Feb 27.
4
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.牛磺熊去氧胆酸可抑制非酒精性脂肪性肝病小鼠的肠道炎症和屏障破坏。
Br J Pharmacol. 2018 Feb;175(3):469-484. doi: 10.1111/bph.14095. Epub 2018 Jan 3.
5
Phytic Acid Improves Hepatic Steatosis, Inflammation, and Oxidative Stress in High-Fat Diet (HFD)-Fed Mice by Modulating the Gut-Liver Axis.植酸通过调节肠-肝轴改善高脂肪饮食(HFD)喂养小鼠的肝脂肪变性、炎症和氧化应激。
J Agric Food Chem. 2022 Sep 14;70(36):11401-11411. doi: 10.1021/acs.jafc.2c04406. Epub 2022 Aug 30.
6
Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.整合组学分析揭示了益津糖通过调节肠道微生物群对肥胖小鼠肝脂肪变性和胰岛素抵抗的影响。
Phytomedicine. 2020 Dec;79:153354. doi: 10.1016/j.phymed.2020.153354. Epub 2020 Sep 21.
7
Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.缺乏 Caspases 1/11 可调节高脂饮食诱导肥胖小鼠肝脏的整体脂质谱和肠道微生物群。
Front Immunol. 2020 Jan 9;10:2926. doi: 10.3389/fimmu.2019.02926. eCollection 2019.
8
Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.红肉火龙果花青素通过调节小鼠肠道微生物群,预防饮食诱导的肥胖、肝脏脂肪变性和胰岛素抵抗。
J Gastroenterol Hepatol. 2016 Aug;31(8):1462-9. doi: 10.1111/jgh.13278.
9
Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.肠道微生物群移植、槲皮素与高脂饮食之间的功能相互作用决定无菌小鼠非酒精性脂肪性肝病的发生。
Mol Nutr Food Res. 2019 Apr;63(8):e1800930. doi: 10.1002/mnfr.201800930. Epub 2019 Feb 4.
10
Triclosan targeting of gut microbiome ameliorates hepatic steatosis in high fat diet-fed mice.三氯生靶向肠道微生物组可改善高脂肪饮食喂养小鼠的肝脂肪变性。
J Antibiot (Tokyo). 2022 Jun;75(6):341-353. doi: 10.1038/s41429-022-00522-w. Epub 2022 Apr 19.

引用本文的文献

1
Exploring the Prevention of Lipid Deposition Caused by High-Fat Diet and Its Mechanism of Action of Fermented Juice Based on Liver Metabolomics and Gut Microbiota.基于肝脏代谢组学和肠道微生物群探究发酵汁对高脂饮食引起的脂质沉积的预防作用及其作用机制
Food Sci Nutr. 2025 Jul 28;13(8):e70449. doi: 10.1002/fsn3.70449. eCollection 2025 Aug.
2
Global Status, Recent Trends, and Knowledge Mapping of Olive Bioactivity Research Through Bibliometric Analysis (2000-2024).通过文献计量分析(2000 - 2024年)对橄榄生物活性研究的全球现状、近期趋势及知识图谱分析
Foods. 2025 Apr 14;14(8):1349. doi: 10.3390/foods14081349.
3
The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease.
中药活性成分调控代谢功能障碍相关脂肪性肝病的多靶点信号通路
Drug Des Devel Ther. 2025 Apr 9;19:2693-2715. doi: 10.2147/DDDT.S514498. eCollection 2025.
4
Chinese herbal medicine improves antioxidant capacity of chicken liver at high stocking density involved gut-liver microbiota axis based on multi-omics technologies.基于多组学技术,中草药通过肠道-肝脏微生物群轴提高高饲养密度下鸡肝脏的抗氧化能力。
Poult Sci. 2025 May;104(5):105015. doi: 10.1016/j.psj.2025.105015. Epub 2025 Mar 11.
5
Naringenin cationic lipid-modified nanoparticles mitigate MASLD progression by modulating lipid homeostasis and gut microbiota.柚皮素阳离子脂质修饰纳米颗粒通过调节脂质稳态和肠道微生物群减轻非酒精性脂肪性肝炎相关肝病进展。
J Nanobiotechnology. 2025 Mar 4;23(1):168. doi: 10.1186/s12951-025-03228-x.
6
Hyperlipidaemia treatment and gut microbiology.高脂血症治疗与肠道微生物学
Front Microbiol. 2025 Jan 10;15:1520252. doi: 10.3389/fmicb.2024.1520252. eCollection 2024.
7
Oleanolic acid attenuates obesity through modulating the lipid metabolism in high-fat diet-fed mice.齐墩果酸通过调节高脂饮食喂养小鼠的脂质代谢来减轻肥胖。
Food Sci Nutr. 2024 Aug 29;12(10):8243-8254. doi: 10.1002/fsn3.4408. eCollection 2024 Oct.
8
Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds.肥胖症和非酒精性脂肪性肝病的创新疗法:关于抗氧化剂、草药、植物化学物质和天然化合物的文献计量学研究
Heliyon. 2024 Aug 8;10(16):e35498. doi: 10.1016/j.heliyon.2024.e35498. eCollection 2024 Aug 30.
9
Gut dysbiosis contributes to the development of Budd-Chiari syndrome through immune imbalance.肠道菌群失调通过免疫失衡促进布加综合征的发生。
mSystems. 2024 Sep 17;9(9):e0079424. doi: 10.1128/msystems.00794-24. Epub 2024 Aug 21.
10
Principal Bioactive Properties of Oleanolic Acid, Its Derivatives, and Analogues.齐墩果酸及其衍生物和类似物的主要生物活性特性。
Molecules. 2024 Jul 12;29(14):3291. doi: 10.3390/molecules29143291.